Hongyu Qin, Jian Zhang, Yilu Zhao, Lihui Zhang, Jinhong Feng, & Lei Zhang. (2023). Discovery of a potent olaparib-chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer. Frontiers Media S.A..
Chicago Style (17th ed.) CitationHongyu Qin, Jian Zhang, Yilu Zhao, Lihui Zhang, Jinhong Feng, and Lei Zhang. Discovery of a Potent Olaparib-chlorambucil Hybrid Inhibitor of PARP1 for the Treatment of Cancer. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationHongyu Qin, et al. Discovery of a Potent Olaparib-chlorambucil Hybrid Inhibitor of PARP1 for the Treatment of Cancer. Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.